Director, Liver Cancer Research, Professor of Medicine, Harvard Medical School
Dr. Andrew X. Zhu is a Professor of Medicine at Harvard Medical School and Director of Liver Cancer Research at Massachusetts General Hospital. His clinical practice focuses on medical and multidisciplinary management of patients with gastrointestinal cancers including liver, bile duct, colorectal, pancreatic, gastroesophageal, and neuroendocrine cancers.  Dr. Zhu is an internationally recognized expert in hepatocellular carcinoma and cholangiocarcinoma.  His clinical and research interests have focused on developing innovative therapies for hepatobiliary cancers, identifying novel molecular markers and genetic mutations, and dissecting the molecular mechanisms of drug resistance to targeted therapy in hepatobiliary cancers.  Dr. Zhu serves on the Hepatobiliary Cancer Committee of the National Comprehensive Cancer Network (NCCN), the Grants Selection Committee of the American Society of Clinical Oncology (ASCO), the Hepatobiliary Cancer Task Force of The NCI Gastrointestinal Cancer Steering Committee (GISC), the American Joint Committee on Cancer (AJCC) Hepatobiliary Task Force, the Hepatocellular Carcinoma Practice Guidelines Committee of the American Association for the Study of Liver Diseases (AASLD), and the Clinical Advisory Board of the Cholangiocarcinoma Foundation.
55 Fruit Street
Boston, MA 02114-2696